Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|January 23, 2025
Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolutionStéphane Rodriguez, Laura Couloume, Juliette Ferrant, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
Journal of Neurology|April 25, 2019
Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesionsXavier Ayrignac, Valérie Rigau, Benoit Lhermitte, et al.
Multiple Sclerosis and Related Disorders|November 29, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysisLisa G Schoof, Brit Ellen Rød, Sahla El Mahdaoui, et al.
European Radiology|April 4, 2025
Evaluation of a deep learning segmentation tool to help detect spinal cord lesions from combined T2 and STIR acquisitions in people with multiple sclerosisBaptiste Lodé, Burhan Rashid Hussein, Cédric Meurée, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunitiesCornelia Laule, Julien Cohen-Adad, Atlee A Witt, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple SclerosisMarie Mainguy, Romain Casey, Sandra Vukusic, et al.
Brain : a Journal of Neurology|June 24, 2020
Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disabilityAnne Kerbrat, Charley Gros, Atef Badji, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 15, 2024
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis SocietyNicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
Pageof 6